Physician profile
Anup Sud
NPI 1316972631
$2,189.01
in general payments reported to CMS, 2019-2025
9 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.48 · 2020: $20.54 · 2021: $453 · 2022: $168 · 2023: $838 · 2024: $413 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $995.57 | 2023-2025 | Corevalve Evolut R, Signia, Avalus |
| Edwards Lifesciences Corporation | $267.12 | 2021-2023 | |
| Abiomed | $258.87 | 2023-2025 | Impella |
| Chiesi USA, INC. | $201.87 | 2021 | |
| Getinge USA Sales, LLC | $143.05 | 2020-2021 | |
| Artivion, INC. | $138.86 | 2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Amds-Ascyrus Medical |
| La Jolla Pharmaceutical Company | $114.71 | 2022 | |
| Davol INC. | $53.48 | 2022 | |
| Foundation Medicine, INC. | $15.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anup Sud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.